TY  - BOOK
AU  - Mrazek,David
TI  - Psychiatric pharmacogenomics
SN  - 9780195367294 (alk. paper)
AV  - RM315 .M73 2010
U1  - 615.788 22
PY  - 2010///
CY  - New York
PB  - Oxford University Press
KW  - Psychotropic drugs
KW  - Pharmacogenomics
KW  - Biotransformation
KW  - genetics
KW  - Psychotropic Drugs
KW  - adverse effects
KW  - Mental Disorders
KW  - drug therapy
KW  - pharmacokinetics
N1  - Includes bibliographical references and index; The language of molecular genetics -- The fourteen genes -- The problem and the solution -- The cytochrome P450 2D6 gene -- The cytochrome P450 2C19 gene -- The cytochrome P450 2C9 gene -- The cytochrome P450 1A2 gene -- The catechol-o-methyltransferase gene -- The norepinephrine transporter gene -- The dopamine transporter gene -- The serotonin transporter gene -- The serotonin 1A receptor gene -- The serotonin 2A receptor gene -- The serotonin 2C receptor gene -- The dopamine D2 receptor gene -- The dopamine D3 receptor gene -- The dopamine D4 receptor gene -- The clinical utility of psychiatric pharmacogenomic testing -- Ethical issues to consider when using pharmacogenomic testing in psychiatric practice -- The future development of psychiatric pharmacogenomic testing
ER  -